Schrödinger Reports Q1 2026 Earnings with Mixed Financial Results
Schrödinger (SDGR) reported Q1 2026 earnings with total revenue of $58.6 million, driven by software and drug discovery segments. The company noted a 12% increase in Annual Contract Value to $28.4 million and a shift toward hosted software revenue. However, it also reported a net loss of $60 million and a decline in software gross margin to 69%.
Tickers: $LLY
Topics: drug discovery financial performance M&A operating expenses revenue software